Shree Ganesh Remedies (NSE:SGRL) Accounts Payable: ₹94 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SGRL Shree Ganesh Remedies Ltd NSE:SGRL
71 GF Score
Price ₹501.05
GF Value ₹589.26
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Shree Ganesh Remedies Accounts Payable?

Shree Ganesh Remedies NSE:SGRL -3.34% 71 Accounts Payable is ₹94 Mil as of Mar. 2026. GuruFocus rates NSE:SGRL with a GF Score™ of 71/100 and a GF Value™ of ₹589.26 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Shree Ganesh Remedies's Accounts Payable for the quarter that ended in Mar. 2026 was ₹94 Mil.

Shree Ganesh Remedies's quarterly Accounts Payable declined from Sep. 2025 (₹95 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹94 Mil).

Shree Ganesh Remedies's annual Accounts Payable declined from Mar. 2024 (₹82 Mil) to Mar. 2025 (₹60 Mil) but then increased from Mar. 2025 (₹60 Mil) to Mar. 2026 (₹94 Mil).

Shree Ganesh Remedies Accounts Payable Related Terms

Shree Ganesh Remedies Accounts Payable Historical Data

* Premium members only.

The historical data trend for Shree Ganesh Remedies's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shree Ganesh Remedies Accounts Payable Chart

Shree Ganesh Remedies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 94.74 145.34 81.88 59.67 94.42

Shree Ganesh Remedies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.67 0.00 95.06 0.00 94.42
NSE:SGRL
71GF Score
Shree Ganesh Remedies Ltd NSE:SGRL
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shree Ganesh Remedies Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ₹94 Mil mean?
Shree Ganesh Remedies (NSE:SGRL) has a Accounts Payable of ₹94 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Shree Ganesh Remedies and its competitors.
Is Shree Ganesh Remedies' Accounts Payable too high?
Shree Ganesh Remedies' current Accounts Payable is ₹94 Mil. Overall, Shree Ganesh Remedies has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shree Ganesh Remedies' Accounts Payable compare to ?
Shree Ganesh Remedies' Accounts Payable of ₹94 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Shree Ganesh Remedies and its competitors. Shree Ganesh Remedies's current Accounts Payable is ₹94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shree Ganesh Remedies stock overvalued right now?
Based on GuruFocus' analysis, Shree Ganesh Remedies (NSE:SGRL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹589.26, compared to a current price of ₹501.05 — trading 15% below its estimated fair value. The current Accounts Payable is ₹94 Mil. Shree Ganesh Remedies' overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Shree Ganesh Remedies (NSE:SGRL), the current Accounts Payable is ₹94 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shree Ganesh Remedies (NSE:SGRL) Overvalued in 2026?

Based on GuruFocus' analysis, Shree Ganesh Remedies stock appears to be undervalued. The current stock price of ₹501.05 is trading 15% below its estimated GF Value™ of ₹589.26. GuruFocus considers Shree Ganesh Remedies to be Modestly Undervalued.

Key valuation signals for NSE:SGRL:

  • Accounts Payable: ₹94 Mil
  • GF Value™: ₹589.26 vs. price of ₹501.05 (15% below fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the NSE:SGRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shree Ganesh Remedies Business Description

Comparable Companies
Other Exchanges 540737:India
Address Plot No. 6002, 6003, 6011 & 6012, GIDC Industrial Estate, Bharuch, Ankleshwar, GJ, IND, 393002
Shree Ganesh Remedies Ltd manufactures drug intermediates, chemicals, and specialty fine chemicals for the pharmaceutical industry. The company offers pharmaceutical and specialty chemical products, including Trityl chloride, Furoyl chloride, and Dinitolmide. The company's business falls under the primary segment of Bulk Drug Intermediaries.
71GF Score

Get the complete analysis for NSE:SGRL

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹501.05
Price
₹589.26
GF Value